GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Universal Ibogaine Inc (TSXV:IBO) » Definitions » Loans Receivable

Universal Ibogaine (TSXV:IBO) Loans Receivable : C$0.00 Mil (As of Jan. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Universal Ibogaine Loans Receivable?

Universal Ibogaine's Loans Receivable for the quarter that ended in Jan. 2024 was C$0.00 Mil.


Universal Ibogaine Loans Receivable Historical Data

The historical data trend for Universal Ibogaine's Loans Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Universal Ibogaine Loans Receivable Chart

Universal Ibogaine Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Jul22 Jul23
Loans Receivable
Get a 7-Day Free Trial - 0.03 - - -

Universal Ibogaine Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Loans Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Universal Ibogaine Loans Receivable Calculation

Loans Receivable are the funds that a company has lent but have not yet been repaid.


Universal Ibogaine Loans Receivable Related Terms

Thank you for viewing the detailed overview of Universal Ibogaine's Loans Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


Universal Ibogaine (TSXV:IBO) Business Description

Traded in Other Exchanges
Address
400 3rd Avenue South west, Suite 1470, Calgary, AB, CAN, T2P 4H2
Universal Ibogaine Inc develops a platform of addiction treatment clinics, which use ibogaine as a primary modality for the interruption and ideally cessation of addictions to primarily opioids such as oxycodone, heroin, fentanyl, as well as alcohol, cocaine, and other stimulants. It runs addiction clinics it has a research partner clinic in Mexico.
Executives
Ian Rabb Senior Officer

Universal Ibogaine (TSXV:IBO) Headlines

No Headlines